Breaking Finance News

Inspiration Healthcare Group (LON:IHC) target price increased to 68.00GBX, issued a ratings update today by finnCap

In a report released on 06/21/2017 finnCap increased the stock price target of Inspiration Healthcare Group (LON:IHC) to 68.00GBX indicating a possible upside of 0.16%.

Yesterday Inspiration Healthcare Group (LON:IHC) traded 0.00% even at 58.50GBX. The company’s 50-day moving average is 60.78GBX and its two hundred day average is 59.25GBX. With the last close down 7.17% relative to the two hundred day average, compared with the S&P 500 Index which has increased 0.04% over the same period. Volume of trade was up over the average, with 8,796 shares of IHC changing hands over the typical 2,544

Performance Chart

Inspiration Healthcare Group (LON:IHC)

Inspiration Healthcare Group has a 52 week low of 53.00GBX and a 52 week high of 73.50GBX with a P/E ratio of 63.50 IHC’s total market value is presently 0 GBX.

Brief Synopsis About Inspiration Healthcare Group (LON:IHC)

Inspiration Healthcare Group plc, formerly Inditherm plc, is a supplier of medical devices mainly in areas of critical care. The Company operates through four segments: Critical Care, Operating Theatre, Home Healthcare, and Central and Unallocated costs. Under the Critical Care segment, the Company's products for premature and sick babies include LifeStart (for deferred cord clamping), Tecotherm Neo (for thermoregulation) and Inspire nCPAP (non-invasive respiratory support). It also sells products for adult and pediatric intensive care in the United Kingdom and Ireland. Under the Operating Theatre segment, the Company's products include the Inditherm Alpha system and a range of warming products for maintaining patient temperature during surgery. Under the Home Healthcare segment, the Company's products include the Inditherm industrial products and a range of products mainly for parenteral feeding and products that are not used in intensive care and the operating theatre.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.